Senolytic CAR T cells reverse senescence-associated pathologies
2020 · Nature · 986 citations
https://doi.org/10.1038/s41586-020-2403-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
3.6K
Citations
15
h-index
15
i10-index
Josef Leibold is an academic researcher from Comprehensive Cancer Center Vienna. The author has contributed to research in topics: Renal cell carcinoma treatment & Ferroptosis and cancer prognosis & CAR-T cell therapy research. The author has an h-index of 15, co-authored 46 publications.
ORCID: 0000-0003-2336-1987Click to start Chat